APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Type 1 Diabetes (T1D)

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Type 1 Diabetes (T1D) Market Analysis and Forecast 2026-2032

Report ID 174043930222 December 2025195 pages

Choose your research edition.

Industry ResearchType 1 Diabetes (T1D) Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Type 1 Diabetes (T1D) Industry Growth and Trends Forecast to 2032106 pages · $3,450 USDMarket StructureGlobal Type 1 Diabetes (T1D) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Type 1 Diabetes (T1D) Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Type 1 Diabetes (T1D) Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global Type 1 Diabetes (T1D) market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Type 1 Diabetes (T1D) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Type 1 Diabetes (T1D) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Type 1 Diabetes (T1D) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Type 1 Diabetes (T1D) is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Type 1 Diabetes (T1D) include Janssen, Sanofi, Sanofi, Novo Nordisk, Merck, Eli Lilly, Samsung Bioepis, Lexicon and Bristol-Myers Squibb, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Type 1 Diabetes (T1D), sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Type 1 Diabetes (T1D), also provides the sales of main regions and countries. Of the upcoming market potential for Type 1 Diabetes (T1D), and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Type 1 Diabetes (T1D) sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Type 1 Diabetes (T1D) market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Type 1 Diabetes (T1D) sales, projected growth trends, production technology, application and end-user industry.

Type 1 Diabetes (T1D) Segment by Company

Janssen

Sanofi

Sanofi

Novo Nordisk

Merck

Eli Lilly

Samsung Bioepis

Lexicon

Bristol-Myers Squibb

Boehringer Ingelheim

Biocon

Astellas

Type 1 Diabetes (T1D) Segment by Type

Long Acting Insulin Analogs

Premix Insulin Analogs

Rapid Acting Insulin Analogs

Type 1 Diabetes (T1D) Segment by Application

Children

Adults

Type 1 Diabetes (T1D) Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Type 1 Diabetes (T1D) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Type 1 Diabetes (T1D) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Type 1 Diabetes (T1D).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Type 1 Diabetes (T1D) in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Type 1 Diabetes (T1D) manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Type 1 Diabetes (T1D) sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Type 1 Diabetes (T1D) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Long Acting Insulin Analogs Major Manufacturers Table 3. Premix Insulin Analogs Major Manufacturers Table 4. Rapid Acting Insulin Analogs Major Manufacturers Table 5. Global Type 1 Diabetes (T1D) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Children Major Manufacturers Table 7. Adults Major Manufacturers Table 8. Type 1 Diabetes (T1D) Industry Trends Table 9. Type 1 Diabetes (T1D) Industry Drivers Table 10. Type 1 Diabetes (T1D) Industry Opportunities and Challenges Table 11. Type 1 Diabetes (T1D) Industry Restraints Table 12. Global Type 1 Diabetes (T1D) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Type 1 Diabetes (T1D) Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Type 1 Diabetes (T1D) Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Type 1 Diabetes (T1D) Revenue Market Share by Region (2021-2026) Table 16. Global Type 1 Diabetes (T1D) Revenue Market Share by Region (2027-2032) Table 17. Global Type 1 Diabetes (T1D) Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Type 1 Diabetes (T1D) Sales by Region (2021-2026) & (k units) Table 19. Global Type 1 Diabetes (T1D) Sales by Region (2027-2032) & (k units) Table 20. Global Type 1 Diabetes (T1D) Sales Market Share by Region (2021-2026) Table 21. Global Type 1 Diabetes (T1D) Sales Market Share by Region (2027-2032) Table 22. Global Type 1 Diabetes (T1D) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Type 1 Diabetes (T1D) Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Type 1 Diabetes (T1D) Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Type 1 Diabetes (T1D) Sales Market Share by Manufacturers (2021-2026) Table 26. Global Type 1 Diabetes (T1D) Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Type 1 Diabetes (T1D) Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Type 1 Diabetes (T1D) Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Type 1 Diabetes (T1D) Manufacturers, Product Type & Application Table 30. Global Type 1 Diabetes (T1D) Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Type 1 Diabetes (T1D) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Type 1 Diabetes (T1D) Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Type 1 Diabetes (T1D) Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Type 1 Diabetes (T1D) Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2021-2026) Table 37. Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2027-2032) Table 38. Global Type 1 Diabetes (T1D) Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (k units) Table 40. Global Type 1 Diabetes (T1D) Sales by Type (2027-2032) & (k units) Table 41. Global Type 1 Diabetes (T1D) Sales Market Share by Type (2021-2026) Table 42. Global Type 1 Diabetes (T1D) Sales Market Share by Type (2027-2032) Table 43. Global Type 1 Diabetes (T1D) Price by Type (2021-2026) & (US$/unit) Table 44. Global Type 1 Diabetes (T1D) Price by Type (2027-2032) & (US$/unit) Table 45. Global Type 1 Diabetes (T1D) Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Type 1 Diabetes (T1D) Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Type 1 Diabetes (T1D) Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2021-2026) Table 49. Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2027-2032) Table 50. Global Type 1 Diabetes (T1D) Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (k units) Table 52. Global Type 1 Diabetes (T1D) Sales by Application (2027-2032) & (k units) Table 53. Global Type 1 Diabetes (T1D) Sales Market Share by Application (2021-2026) Table 54. Global Type 1 Diabetes (T1D) Sales Market Share by Application (2027-2032) Table 55. Global Type 1 Diabetes (T1D) Price by Application (2021-2026) & (US$/unit) Table 56. Global Type 1 Diabetes (T1D) Price by Application (2027-2032) & (US$/unit) Table 57. Janssen Company Information Table 58. Janssen Business Overview Table 59. Janssen Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Janssen Type 1 Diabetes (T1D) Product Portfolio Table 61. Janssen Recent Development Table 62. Sanofi Company Information Table 63. Sanofi Business Overview Table 64. Sanofi Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 65. Sanofi Type 1 Diabetes (T1D) Product Portfolio Table 66. Sanofi Recent Development Table 67. Sanofi Company Information Table 68. Sanofi Business Overview Table 69. Sanofi Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 70. Sanofi Type 1 Diabetes (T1D) Product Portfolio Table 71. Sanofi Recent Development Table 72. Novo Nordisk Company Information Table 73. Novo Nordisk Business Overview Table 74. Novo Nordisk Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 75. Novo Nordisk Type 1 Diabetes (T1D) Product Portfolio Table 76. Novo Nordisk Recent Development Table 77. Merck Company Information Table 78. Merck Business Overview Table 79. Merck Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 80. Merck Type 1 Diabetes (T1D) Product Portfolio Table 81. Merck Recent Development Table 82. Eli Lilly Company Information Table 83. Eli Lilly Business Overview Table 84. Eli Lilly Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 85. Eli Lilly Type 1 Diabetes (T1D) Product Portfolio Table 86. Eli Lilly Recent Development Table 87. Samsung Bioepis Company Information Table 88. Samsung Bioepis Business Overview Table 89. Samsung Bioepis Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 90. Samsung Bioepis Type 1 Diabetes (T1D) Product Portfolio Table 91. Samsung Bioepis Recent Development Table 92. Lexicon Company Information Table 93. Lexicon Business Overview Table 94. Lexicon Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 95. Lexicon Type 1 Diabetes (T1D) Product Portfolio Table 96. Lexicon Recent Development Table 97. Bristol-Myers Squibb Company Information Table 98. Bristol-Myers Squibb Business Overview Table 99. Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 100. Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Portfolio Table 101. Bristol-Myers Squibb Recent Development Table 102. Boehringer Ingelheim Company Information Table 103. Boehringer Ingelheim Business Overview Table 104. Boehringer Ingelheim Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 105. Boehringer Ingelheim Type 1 Diabetes (T1D) Product Portfolio Table 106. Boehringer Ingelheim Recent Development Table 107. Biocon Company Information Table 108. Biocon Business Overview Table 109. Biocon Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 110. Biocon Type 1 Diabetes (T1D) Product Portfolio Table 111. Biocon Recent Development Table 112. Astellas Company Information Table 113. Astellas Business Overview Table 114. Astellas Type 1 Diabetes (T1D) Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 115. Astellas Type 1 Diabetes (T1D) Product Portfolio Table 116. Astellas Recent Development Table 117. North America Type 1 Diabetes (T1D) Revenue by Type (2021-2026) & (US$ Million) Table 118. North America Type 1 Diabetes (T1D) Revenue by Type (2027-2032) & (US$ Million) Table 119. North America Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (k units) Table 120. North America Type 1 Diabetes (T1D) Sales by Type (2027-2032) & (k units) Table 121. North America Type 1 Diabetes (T1D) Sales Price by Type (2021-2026) & (US$/unit) Table 122. North America Type 1 Diabetes (T1D) Sales Price by Type (2027-2032) & (US$/unit) Table 123. North America Type 1 Diabetes (T1D) Revenue by Application (2021-2026) & (US$ Million) Table 124. North America Type 1 Diabetes (T1D) Revenue by Application (2027-2032) & (US$ Million) Table 125. North America Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (k units) Table 126. North America Type 1 Diabetes (T1D) Sales by Application (2027-2032) & (k units) Table 127. North America Type 1 Diabetes (T1D) Sales Price by Application (2021-2026) & (US$/unit) Table 128. North America Type 1 Diabetes (T1D) Sales Price by Application (2027-2032) & (US$/unit) Table 129. North America Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. North America Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. North America Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. North America Type 1 Diabetes (T1D) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 133. North America Type 1 Diabetes (T1D) Sales by Country (2021-2026) & (k units) Table 134. North America Type 1 Diabetes (T1D) Sales by Country (2027-2032) & (k units) Table 135. North America Type 1 Diabetes (T1D) Sales Price by Country (2021-2026) & (US$/unit) Table 136. North America Type 1 Diabetes (T1D) Sales Price by Country (2027-2032) & (US$/unit) Table 137. United States Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 138. Canada Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 139. Mexico Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 140. Europe Type 1 Diabetes (T1D) Revenue by Type (2021-2026) & (US$ Million) Table 141. Europe Type 1 Diabetes (T1D) Revenue by Type (2027-2032) & (US$ Million) Table 142. Europe Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (k units) Table 143. Europe Type 1 Diabetes (T1D) Sales by Type (2027-2032) & (k units) Table 144. Europe Type 1 Diabetes (T1D) Sales Price by Type (2021-2026) & (US$/unit) Table 145. Europe Type 1 Diabetes (T1D) Sales Price by Type (2027-2032) & (US$/unit) Table 146. Europe Type 1 Diabetes (T1D) Revenue by Application (2021-2026) & (US$ Million) Table 147. Europe Type 1 Diabetes (T1D) Revenue by Application (2027-2032) & (US$ Million) Table 148. Europe Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (k units) Table 149. Europe Type 1 Diabetes (T1D) Sales by Application (2027-2032) & (k units) Table 150. Europe Type 1 Diabetes (T1D) Sales Price by Application (2021-2026) & (US$/unit) Table 151. Europe Type 1 Diabetes (T1D) Sales Price by Application (2027-2032) & (US$/unit) Table 152. Europe Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 153. Europe Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 154. Europe Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 155. Europe Type 1 Diabetes (T1D) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 156. Europe Type 1 Diabetes (T1D) Sales by Country (2021-2026) & (k units) Table 157. Europe Type 1 Diabetes (T1D) Sales by Country (2027-2032) & (k units) Table 158. Europe Type 1 Diabetes (T1D) Sales Price by Country (2021-2026) & (US$/unit) Table 159. Europe Type 1 Diabetes (T1D) Sales Price by Country (2027-2032) & (US$/unit) Table 160. Germany Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 161. France Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 162. U.K. Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 163. Italy Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 164. Russia Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 165. Spain Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 166. Netherlands Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 167. Switzerland Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 168. Sweden Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 169. Poland Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 170. China Type 1 Diabetes (T1D) Revenue by Type (2021-2026) & (US$ Million) Table 171. China Type 1 Diabetes (T1D) Revenue by Type (2027-2032) & (US$ Million) Table 172. China Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (k units) Table 173. China Type 1 Diabetes (T1D) Sales by Type (2027-2032) & (k units) Table 174. China Type 1 Diabetes (T1D) Sales Price by Type (2021-2026) & (US$/unit) Table 175. China Type 1 Diabetes (T1D) Sales Price by Type (2027-2032) & (US$/unit) Table 176. China Type 1 Diabetes (T1D) Revenue by Application (2021-2026) & (US$ Million) Table 177. China Type 1 Diabetes (T1D) Revenue by Application (2027-2032) & (US$ Million) Table 178. China Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (k units) Table 179. China Type 1 Diabetes (T1D) Sales by Application (2027-2032) & (k units) Table 180. China Type 1 Diabetes (T1D) Sales Price by Application (2021-2026) & (US$/unit) Table 181. China Type 1 Diabetes (T1D) Sales Price by Application (2027-2032) & (US$/unit) Table 182. Asia Type 1 Diabetes (T1D) Revenue by Type (2021-2026) & (US$ Million) Table 183. Asia Type 1 Diabetes (T1D) Revenue by Type (2027-2032) & (US$ Million) Table 184. Asia Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (k units) Table 185. Asia Type 1 Diabetes (T1D) Sales by Type (2027-2032) & (k units) Table 186. Asia Type 1 Diabetes (T1D) Sales Price by Type (2021-2026) & (US$/unit) Table 187. Asia Type 1 Diabetes (T1D) Sales Price by Type (2027-2032) & (US$/unit) Table 188. Asia Type 1 Diabetes (T1D) Revenue by Application (2021-2026) & (US$ Million) Table 189. Asia Type 1 Diabetes (T1D) Revenue by Application (2027-2032) & (US$ Million) Table 190. Asia Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (k units) Table 191. Asia Type 1 Diabetes (T1D) Sales by Application (2027-2032) & (k units) Table 192. Asia Type 1 Diabetes (T1D) Sales Price by Application (2021-2026) & (US$/unit) Table 193. Asia Type 1 Diabetes (T1D) Sales Price by Application (2027-2032) & (US$/unit) Table 194. Asia Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 195. Asia Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 196. Asia Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 197. Asia Type 1 Diabetes (T1D) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 198. Asia Type 1 Diabetes (T1D) Sales by Country (2021-2026) & (k units) Table 199. Asia Type 1 Diabetes (T1D) Sales by Country (2027-2032) & (k units) Table 200. Asia Type 1 Diabetes (T1D) Sales Price by Country (2021-2026) & (US$/unit) Table 201. Asia Type 1 Diabetes (T1D) Sales Price by Country (2027-2032) & (US$/unit) Table 202. Japan Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 203. South Korea Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 204. India Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 205. Australia Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 206. Taiwan Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 207. Southeast Asia Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 208. SAMEA Type 1 Diabetes (T1D) Revenue by Type (2021-2026) & (US$ Million) Table 209. SAMEA Type 1 Diabetes (T1D) Revenue by Type (2027-2032) & (US$ Million) Table 210. SAMEA Type 1 Diabetes (T1D) Sales by Type (2021-2026) & (k units) Table 211. SAMEA Type 1 Diabetes (T1D) Sales by Type (2027-2032) & (k units) Table 212. SAMEA Type 1 Diabetes (T1D) Sales Price by Type (2021-2026) & (US$/unit) Table 213. SAMEA Type 1 Diabetes (T1D) Sales Price by Type (2027-2032) & (US$/unit) Table 214. SAMEA Type 1 Diabetes (T1D) Revenue by Application (2021-2026) & (US$ Million) Table 215. SAMEA Type 1 Diabetes (T1D) Revenue by Application (2027-2032) & (US$ Million) Table 216. SAMEA Type 1 Diabetes (T1D) Sales by Application (2021-2026) & (k units) Table 217. SAMEA Type 1 Diabetes (T1D) Sales by Application (2027-2032) & (k units) Table 218. SAMEA Type 1 Diabetes (T1D) Sales Price by Application (2021-2026) & (US$/unit) Table 219. SAMEA Type 1 Diabetes (T1D) Sales Price by Application (2027-2032) & (US$/unit) Table 220. SAMEA Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 221. SAMEA Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 222. SAMEA Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 223. SAMEA Type 1 Diabetes (T1D) Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 224. SAMEA Type 1 Diabetes (T1D) Sales by Country (2021-2026) & (k units) Table 225. SAMEA Type 1 Diabetes (T1D) Sales by Country (2027-2032) & (k units) Table 226. SAMEA Type 1 Diabetes (T1D) Sales Price by Country (2021-2026) & (US$/unit) Table 227. SAMEA Type 1 Diabetes (T1D) Sales Price by Country (2027-2032) & (US$/unit) Table 228. Brazil Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 229. Argentina Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 230. Chile Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 231. Colombia Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 232. Peru Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 233. Saudi Arabia Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 234. Israel Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 235. UAE Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 236. Turkey Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 237. Iran Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 238. Egypt Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Table 239. Key Raw Materials Table 240. Raw Materials Key Suppliers Table 241. Type 1 Diabetes (T1D) Distributors List Table 242. Type 1 Diabetes (T1D) Customers List Table 243. Research Programs/Design for This Report Table 244. Authors List of This Report Table 245. Secondary Sources Table 246. Primary Sources List of Figures Figure 1. Type 1 Diabetes (T1D) Image Figure 2. Global Type 1 Diabetes (T1D) Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Type 1 Diabetes (T1D) Market Size Share 2021 VS 2025 VS 2032 Figure 4. Long Acting Insulin Analogs Image Figure 5. Premix Insulin Analogs Image Figure 6. Rapid Acting Insulin Analogs Image Figure 7. Global Type 1 Diabetes (T1D) Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Type 1 Diabetes (T1D) Market Size Share 2021 VS 2025 VS 2032 Figure 9. Children Image Figure 10. Adults Image Figure 11. Global Type 1 Diabetes (T1D) Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Type 1 Diabetes (T1D) Revenue (2021-2032) & (US$ Million) Figure 13. Global Type 1 Diabetes (T1D) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Type 1 Diabetes (T1D) Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Type 1 Diabetes (T1D) Revenue Market Share by Region (2021-2032) Figure 16. Global Type 1 Diabetes (T1D) Sales (2021-2032) & (k units) Figure 17. Global Type 1 Diabetes (T1D) Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Type 1 Diabetes (T1D) Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Type 1 Diabetes (T1D) Sales YoY (2021-2032) & (k units) Figure 20. Europe Type 1 Diabetes (T1D) Sales YoY (2021-2032) & (k units) Figure 21. China Type 1 Diabetes (T1D) Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Type 1 Diabetes (T1D) Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Type 1 Diabetes (T1D) Sales YoY (2021-2032) & (k units) Figure 24. Global Type 1 Diabetes (T1D) Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Type 1 Diabetes (T1D) Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Type 1 Diabetes (T1D) Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Type 1 Diabetes (T1D) Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2021-2032) Figure 30. Global Type 1 Diabetes (T1D) Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Type 1 Diabetes (T1D) Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Type 1 Diabetes (T1D) Sales Market Share by Type (2021-2032) Figure 33. Global Type 1 Diabetes (T1D) Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Type 1 Diabetes (T1D) Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2021-2032) Figure 36. Global Type 1 Diabetes (T1D) Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Type 1 Diabetes (T1D) Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Type 1 Diabetes (T1D) Sales Market Share by Application (2021-2032) Figure 39. North America Type 1 Diabetes (T1D) Revenue Share by Type (2021-2032) Figure 40. North America Type 1 Diabetes (T1D) Sales Share by Type (2021-2032) Figure 41. North America Type 1 Diabetes (T1D) Revenue Share by Application (2021-2032) Figure 42. North America Type 1 Diabetes (T1D) Sales Share by Application (2021-2032) Figure 43. North America Type 1 Diabetes (T1D) Revenue Share by Country (2021-2032) Figure 44. North America Type 1 Diabetes (T1D) Sales Share by Country (2021-2032) Figure 45. Europe Type 1 Diabetes (T1D) Revenue Share by Type (2021-2032) Figure 46. Europe Type 1 Diabetes (T1D) Sales Share by Type (2021-2032) Figure 47. Europe Type 1 Diabetes (T1D) Revenue Share by Application (2021-2032) Figure 48. Europe Type 1 Diabetes (T1D) Sales Share by Application (2021-2032) Figure 49. Europe Type 1 Diabetes (T1D) Revenue Share by Country (2021-2032) Figure 50. Europe Type 1 Diabetes (T1D) Sales Share by Country (2021-2032) Figure 51. China Type 1 Diabetes (T1D) Revenue Share by Type (2021-2032) Figure 52. China Type 1 Diabetes (T1D) Sales Share by Type (2021-2032) Figure 53. China Type 1 Diabetes (T1D) Revenue Share by Application (2021-2032) Figure 54. China Type 1 Diabetes (T1D) Sales Share by Application (2021-2032) Figure 55. Asia Type 1 Diabetes (T1D) Revenue Share by Type (2021-2032) Figure 56. Asia Type 1 Diabetes (T1D) Sales Share by Type (2021-2032) Figure 57. Asia Type 1 Diabetes (T1D) Revenue Share by Application (2021-2032) Figure 58. Asia Type 1 Diabetes (T1D) Sales Share by Application (2021-2032) Figure 59. Asia Type 1 Diabetes (T1D) Revenue Share by Country (2021-2032) Figure 60. Asia Type 1 Diabetes (T1D) Sales Share by Country (2021-2032) Figure 61. SAMEA Type 1 Diabetes (T1D) Revenue Share by Type (2021-2032) Figure 62. SAMEA Type 1 Diabetes (T1D) Sales Share by Type (2021-2032) Figure 63. SAMEA Type 1 Diabetes (T1D) Revenue Share by Application (2021-2032) Figure 64. SAMEA Type 1 Diabetes (T1D) Sales Share by Application (2021-2032) Figure 65. SAMEA Type 1 Diabetes (T1D) Revenue Share by Country (2021-2032) Figure 66. SAMEA Type 1 Diabetes (T1D) Sales Share by Country (2021-2032) Figure 67. Type 1 Diabetes (T1D) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Type 1 Diabetes (T1D) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Long Acting Insulin Analogs
  • Premix Insulin Analogs
  • Rapid Acting Insulin Analogs
Applications
  • Children
  • Adults
Companies covered
  • Janssen
  • Sanofi
  • Sanofi
  • Novo Nordisk
  • Merck
  • Eli Lilly
  • Samsung Bioepis
  • Lexicon
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Biocon
  • Astellas

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Type 1 Diabetes (T1D) Market by Type
  3. 1.2.1 Global Type 1 Diabetes (T1D) Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Long Acting Insulin Analogs
  5. 1.2.3 Premix Insulin Analogs
  6. 1.2.4 Rapid Acting Insulin Analogs
  7. 1.3 Type 1 Diabetes (T1D) Market by Application
  8. 1.3.1 Global Type 1 Diabetes (T1D) Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Children
  10. 1.3.3 Adults
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Type 1 Diabetes (T1D) Market Dynamics
  1. 2.1 Type 1 Diabetes (T1D) Industry Trends
  2. 2.2 Type 1 Diabetes (T1D) Industry Drivers
  3. 2.3 Type 1 Diabetes (T1D) Industry Opportunities and Challenges
  4. 2.4 Type 1 Diabetes (T1D) Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Type 1 Diabetes (T1D) Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Type 1 Diabetes (T1D) Revenue by Region
  3. 3.2.1 Global Type 1 Diabetes (T1D) Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Type 1 Diabetes (T1D) Revenue by Region (2021-2026)
  5. 3.2.3 Global Type 1 Diabetes (T1D) Revenue by Region (2027-2032)
  6. 3.2.4 Global Type 1 Diabetes (T1D) Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Type 1 Diabetes (T1D) Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Type 1 Diabetes (T1D) Sales by Region
  9. 3.4.1 Global Type 1 Diabetes (T1D) Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Type 1 Diabetes (T1D) Sales by Region (2021-2026)
  11. 3.4.3 Global Type 1 Diabetes (T1D) Sales by Region (2027-2032)
  12. 3.4.4 Global Type 1 Diabetes (T1D) Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Type 1 Diabetes (T1D) Revenue by Manufacturers
  2. 4.1.1 Global Type 1 Diabetes (T1D) Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Type 1 Diabetes (T1D) Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Type 1 Diabetes (T1D) Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Type 1 Diabetes (T1D) Sales by Manufacturers
  6. 4.2.1 Global Type 1 Diabetes (T1D) Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Type 1 Diabetes (T1D) Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Type 1 Diabetes (T1D) Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Type 1 Diabetes (T1D) Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Type 1 Diabetes (T1D) Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Type 1 Diabetes (T1D) Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Type 1 Diabetes (T1D) Manufacturers, Product Type & Application
  13. 4.7 Global Type 1 Diabetes (T1D) Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Type 1 Diabetes (T1D) Market CR5 and HHI
  16. 4.8.2 2025 Type 1 Diabetes (T1D) Tier 1, Tier 2, and Tier 3
5 Type 1 Diabetes (T1D) Market by Type
  1. 5.1 Global Type 1 Diabetes (T1D) Revenue by Type
  2. 5.1.1 Global Type 1 Diabetes (T1D) Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Type 1 Diabetes (T1D) Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Type 1 Diabetes (T1D) Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Type 1 Diabetes (T1D) Sales by Type
  6. 5.2.1 Global Type 1 Diabetes (T1D) Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Type 1 Diabetes (T1D) Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Type 1 Diabetes (T1D) Sales Market Share by Type (2021-2032)
  9. 5.3 Global Type 1 Diabetes (T1D) Price by Type
6 Type 1 Diabetes (T1D) Market by Application
  1. 6.1 Global Type 1 Diabetes (T1D) Revenue by Application
  2. 6.1.1 Global Type 1 Diabetes (T1D) Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Type 1 Diabetes (T1D) Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Type 1 Diabetes (T1D) Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Type 1 Diabetes (T1D) Sales by Application
  6. 6.2.1 Global Type 1 Diabetes (T1D) Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Type 1 Diabetes (T1D) Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Type 1 Diabetes (T1D) Sales Market Share by Application (2021-2032)
  9. 6.3 Global Type 1 Diabetes (T1D) Price by Application
7 Company Profiles
  1. 7.1 Janssen
  2. 7.1.1 Janssen Company Information
  3. 7.1.2 Janssen Business Overview
  4. 7.1.3 Janssen Type 1 Diabetes (T1D) Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Janssen Type 1 Diabetes (T1D) Product Portfolio
  6. 7.1.5 Janssen Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Type 1 Diabetes (T1D) Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Type 1 Diabetes (T1D) Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Sanofi
  14. 7.3.1 Sanofi Company Information
  15. 7.3.2 Sanofi Business Overview
  16. 7.3.3 Sanofi Type 1 Diabetes (T1D) Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Sanofi Type 1 Diabetes (T1D) Product Portfolio
  18. 7.3.5 Sanofi Recent Developments
  19. 7.4 Novo Nordisk
  20. 7.4.1 Novo Nordisk Company Information
  21. 7.4.2 Novo Nordisk Business Overview
  22. 7.4.3 Novo Nordisk Type 1 Diabetes (T1D) Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Novo Nordisk Type 1 Diabetes (T1D) Product Portfolio
  24. 7.4.5 Novo Nordisk Recent Developments
  25. 7.5 Merck
  26. 7.5.1 Merck Company Information
  27. 7.5.2 Merck Business Overview
  28. 7.5.3 Merck Type 1 Diabetes (T1D) Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Merck Type 1 Diabetes (T1D) Product Portfolio
  30. 7.5.5 Merck Recent Developments
  31. 7.6 Eli Lilly
  32. 7.6.1 Eli Lilly Company Information
  33. 7.6.2 Eli Lilly Business Overview
  34. 7.6.3 Eli Lilly Type 1 Diabetes (T1D) Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Eli Lilly Type 1 Diabetes (T1D) Product Portfolio
  36. 7.6.5 Eli Lilly Recent Developments
  37. 7.7 Samsung Bioepis
  38. 7.7.1 Samsung Bioepis Company Information
  39. 7.7.2 Samsung Bioepis Business Overview
  40. 7.7.3 Samsung Bioepis Type 1 Diabetes (T1D) Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Samsung Bioepis Type 1 Diabetes (T1D) Product Portfolio
  42. 7.7.5 Samsung Bioepis Recent Developments
  43. 7.8 Lexicon
  44. 7.8.1 Lexicon Company Information
  45. 7.8.2 Lexicon Business Overview
  46. 7.8.3 Lexicon Type 1 Diabetes (T1D) Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Lexicon Type 1 Diabetes (T1D) Product Portfolio
  48. 7.8.5 Lexicon Recent Developments
  49. 7.9 Bristol-Myers Squibb
  50. 7.9.1 Bristol-Myers Squibb Company Information
  51. 7.9.2 Bristol-Myers Squibb Business Overview
  52. 7.9.3 Bristol-Myers Squibb Type 1 Diabetes (T1D) Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Bristol-Myers Squibb Type 1 Diabetes (T1D) Product Portfolio
  54. 7.9.5 Bristol-Myers Squibb Recent Developments
  55. 7.10 Boehringer Ingelheim
  56. 7.10.1 Boehringer Ingelheim Company Information
  57. 7.10.2 Boehringer Ingelheim Business Overview
  58. 7.10.3 Boehringer Ingelheim Type 1 Diabetes (T1D) Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Boehringer Ingelheim Type 1 Diabetes (T1D) Product Portfolio
  60. 7.10.5 Boehringer Ingelheim Recent Developments
  61. 7.11 Biocon
  62. 7.11.1 Biocon Company Information
  63. 7.11.2 Biocon Business Overview
  64. 7.11.3 Biocon Type 1 Diabetes (T1D) Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Biocon Type 1 Diabetes (T1D) Product Portfolio
  66. 7.11.5 Biocon Recent Developments
  67. 7.12 Astellas
  68. 7.12.1 Astellas Company Information
  69. 7.12.2 Astellas Business Overview
  70. 7.12.3 Astellas Type 1 Diabetes (T1D) Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Astellas Type 1 Diabetes (T1D) Product Portfolio
  72. 7.12.5 Astellas Recent Developments
8 North America
  1. 8.1 North America Type 1 Diabetes (T1D) Market Size by Type
  2. 8.1.1 North America Type 1 Diabetes (T1D) Revenue by Type (2021-2032)
  3. 8.1.2 North America Type 1 Diabetes (T1D) Sales by Type (2021-2032)
  4. 8.1.3 North America Type 1 Diabetes (T1D) Price by Type (2021-2032)
  5. 8.2 North America Type 1 Diabetes (T1D) Market Size by Application
  6. 8.2.1 North America Type 1 Diabetes (T1D) Revenue by Application (2021-2032)
  7. 8.2.2 North America Type 1 Diabetes (T1D) Sales by Application (2021-2032)
  8. 8.2.3 North America Type 1 Diabetes (T1D) Price by Application (2021-2032)
  9. 8.3 North America Type 1 Diabetes (T1D) Market Size by Country
  10. 8.3.1 North America Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Type 1 Diabetes (T1D) Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Type 1 Diabetes (T1D) Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Type 1 Diabetes (T1D) Market Size by Type
  2. 9.1.1 Europe Type 1 Diabetes (T1D) Revenue by Type (2021-2032)
  3. 9.1.2 Europe Type 1 Diabetes (T1D) Sales by Type (2021-2032)
  4. 9.1.3 Europe Type 1 Diabetes (T1D) Price by Type (2021-2032)
  5. 9.2 Europe Type 1 Diabetes (T1D) Market Size by Application
  6. 9.2.1 Europe Type 1 Diabetes (T1D) Revenue by Application (2021-2032)
  7. 9.2.2 Europe Type 1 Diabetes (T1D) Sales by Application (2021-2032)
  8. 9.2.3 Europe Type 1 Diabetes (T1D) Price by Application (2021-2032)
  9. 9.3 Europe Type 1 Diabetes (T1D) Market Size by Country
  10. 9.3.1 Europe Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Type 1 Diabetes (T1D) Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Type 1 Diabetes (T1D) Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Type 1 Diabetes (T1D) Market Size by Type
  2. 10.1.1 China Type 1 Diabetes (T1D) Revenue by Type (2021-2032)
  3. 10.1.2 China Type 1 Diabetes (T1D) Sales by Type (2021-2032)
  4. 10.1.3 China Type 1 Diabetes (T1D) Price by Type (2021-2032)
  5. 10.2 China Type 1 Diabetes (T1D) Market Size by Application
  6. 10.2.1 China Type 1 Diabetes (T1D) Revenue by Application (2021-2032)
  7. 10.2.2 China Type 1 Diabetes (T1D) Sales by Application (2021-2032)
  8. 10.2.3 China Type 1 Diabetes (T1D) Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Type 1 Diabetes (T1D) Market Size by Type
  2. 11.1.1 Asia Type 1 Diabetes (T1D) Revenue by Type (2021-2032)
  3. 11.1.2 Asia Type 1 Diabetes (T1D) Sales by Type (2021-2032)
  4. 11.1.3 Asia Type 1 Diabetes (T1D) Price by Type (2021-2032)
  5. 11.2 Asia Type 1 Diabetes (T1D) Market Size by Application
  6. 11.2.1 Asia Type 1 Diabetes (T1D) Revenue by Application (2021-2032)
  7. 11.2.2 Asia Type 1 Diabetes (T1D) Sales by Application (2021-2032)
  8. 11.2.3 Asia Type 1 Diabetes (T1D) Price by Application (2021-2032)
  9. 11.3 Asia Type 1 Diabetes (T1D) Market Size by Country
  10. 11.3.1 Asia Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Type 1 Diabetes (T1D) Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Type 1 Diabetes (T1D) Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Type 1 Diabetes (T1D) Market Size by Type
  2. 12.1.1 SAMEA Type 1 Diabetes (T1D) Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Type 1 Diabetes (T1D) Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Type 1 Diabetes (T1D) Price by Type (2021-2032)
  5. 12.2 SAMEA Type 1 Diabetes (T1D) Market Size by Application
  6. 12.2.1 SAMEA Type 1 Diabetes (T1D) Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Type 1 Diabetes (T1D) Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Type 1 Diabetes (T1D) Price by Application (2021-2032)
  9. 12.3 SAMEA Type 1 Diabetes (T1D) Market Size by Country
  10. 12.3.1 SAMEA Type 1 Diabetes (T1D) Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Type 1 Diabetes (T1D) Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Type 1 Diabetes (T1D) Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Type 1 Diabetes (T1D) Value Chain Analysis
  2. 13.1.1 Type 1 Diabetes (T1D) Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Type 1 Diabetes (T1D) Production Mode & Process
  6. 13.2 Type 1 Diabetes (T1D) Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Type 1 Diabetes (T1D) Distributors
  9. 13.2.3 Type 1 Diabetes (T1D) Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst